3,3′,5′-Triiodo-L-thyronine reduces efficiency of mRNA knockdown by antisense oligodeoxynucleotides: A study with pyroglutamyl aminopeptidase II in adenohypophysis

Oligonucleotides

Volumn 14, Issue 3, 2004, Pages 176-190

  Cruz, Raymundo ^a   Chávez Gutiérrez, Lucia ^a   Joseph Bravo, Patricia ^a   Charli, Jean Louis ^a  

^a INSTITUTO DE BIOTECNOLOGÍA   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

5 OXOPROLYL PEPTIDASE; ANTISENSE OLIGODEOXYNUCLEOTIDE; MESSENGER RNA; OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATE; PEPTIDASE; PROTIRELIN RECEPTOR; THYRONINE DERIVATIVE; THYROTROPIN RELEASING HORMONE RECEPTOR 1; UNCLASSIFIED DRUG; 3,3',5' TRIIODOTHYRONINE; AMINOPEPTIDASE; ANTISENSE OLIGONUCLEOTIDE; DRUG DERIVATIVE; PYROGLUTAMIC ACID; PYROGLUTAMYL PEPTIDASE II; PYROGLUTAMYL-PEPTIDASE II;

ADENOHYPOPHYSIS; ARTICLE; ENZYME INDUCTION; GENE TARGETING; GENETIC TRANSFECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; ANIMAL; CELL CULTURE; DOWN REGULATION; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; FEMALE; GENETICS; METABOLISM; RAT; WISTAR RAT;

AMINOPEPTIDASES; ANIMALS; CELLS, CULTURED; DOWN-REGULATION; FEMALE; OLIGONUCLEOTIDES, ANTISENSE; PITUITARY GLAND, ANTERIOR; PYRROLIDONECARBOXYLIC ACID; RATS; RATS, WISTAR; RECEPTORS, THYROTROPIN-RELEASING HORMONE; RNA, MESSENGER; TRIIODOTHYRONINE, REVERSE;

EID: 5444229937     PISSN: 15454576     EISSN: None     Source Type: Journal    
DOI: 10.1089/oli.2004.14.176     Document Type: Article

References (47)

1. AGUILAR VALLES, A. (2002). BSc. thesis, National University of México.
2. BAUER, K. (1988). Degradation and biological inactivation of thyrotropin releasing hormone (TRH): Regulation of the membrane bound TRH-degrading enzyme from rat anterior pituitary by estrogens and thyroid hormones. Biochimie 70, 69-74.
3. BAUER, K., CARMELIET, P., SCHULZ, M., BAES, M., and DENEF, C. (1990). Regulation and cellular localization of the membrane bound thyrotropin-releasing hormone-degrading enzyme in primary cultures of neuronal, glial and adenohypophyseal cells. Endocrinology 127, 1224-1233.
4. BRUKNER, I., and TREMBLAY, G.A. (2000). Cellular proteins prevent antisense phosphorothioate oligonucleotide (SdT18) to target sense RNA (rA18): Development of a new in vitro assay. Biochemistry 39, 11463-11466.
5. CERRITELLI, S.M., and CROUCH, R.J. (1998). Cloning, expression and mapping of ribonucleases H of human and mouse related to bacterial RNAse HI. Genomics 53, 300-307.
6. CHARLI, J.L., VARGAS, M.A., CISNEROS, M., DE GORTARI, P., BAEZA, M.A., JASSO, P., BOURDAIS, J., PÉREZ, P., URIBE R.M., and JOSEPH-BRAVO, P. (1998). TRH inactivation in the extracellular compartment: Role of pyroglutamyl peptidase II. Neurobiology 6, 45-57.
7. CHOMCZYNSKY, P., and SACCHI, N. (1987). Single-step method of RNA isolation by acid guanidinium thiocyanatephenol-chloroform extraction. Anal. Biochem. 162, 156-159.
8. CRUZ, R., JOSEPH-BRAVO, P., and CHARLI, J.L. (2004). Pyroglutamyl aminopeptidase II is expressed in a subpopulation of lactotrophs but not in thyrotrophs: Its knockdown increases TRH-induced prolactin but not thyrotropin secretion. Annual Meeting of the Endocrine Society, New Orleans, Louisiana.
9. FRANK, P., BRAUNSHOFER-REITER, C., WINTERSBERGER, U., GRIMM, R., and BUSEN, W. (1998). Cloning of the cDNA encoding the large subunit of human RNase HI, a homologue of the prokaryotic RNase HII. Proc. Natl. Acad. Sci. USA 95, 12872-12877.
10. GERSHENGORN, M.C., and OSMAN, R. (1996). Molecular and cellular biology of thyrotropin-releasing hormone receptors. Physiol. Rev. 76, 175-191.
11. GRIFMAN, M., and SOREQ, H. (1997). Differentiation intensifies the susceptibility of pheochromocytoma cells to antisense oligodeoxynucleotide- dependent suppression of acetylcholinesterase activity. Antisense Nucleic Acid Drug Dev. 7, 351-359.
12. HEMMRICH, K., SUSCHEK, C.V., LERZYNSKI, G., SCHNORR, O., and KOLB-BACHOFEN, V. (2003). Specific iNOS-targeted antisense knockdown in endothelial cells. Am. J. Physiol. Cell Physiol. 285, C489-C498.
13. HEUER, H., SCHÄFER, M.K., and BAUER, K. (1998). The thyrotropin-releasing hormone-degrading ectoenzyme: The third element of the thyrotropin-releasing hormone-signaling system. Thyroid 8, 915-920.
14. KRIEG, A.M. (2002). CpG motifs in bacterial DNA and their immune effects. Annu. Rev. Immunol. 20, 709-760.
15. LEBEDEVA, I., and STEIN, C.A. (2001). Antisense oligonucleotides: Promise and reality. Annu. Rev. Pharmacol. Toxicol. 41, 403-419.
16. LEWIS, J.G., LIN, K.-Y., KOTHAVALE, A., FLANAGAN, W.M., MATTEUCCI, M.D., DEPRINCE, R.B., MOOK, R.A., Jr., HENDREN, R.W., and WAGNER, R.W. (1996). A serum-resistant cytofectin for cellular delivery of antisense oligodeoxynucleotides and plasmid DNA. Proc. Natl. Acad. Sci. USA 93, 3176-3181.
17. LIMA, W.F., WU, H., NICHOLS, J.G., MANALILI, S.M., DRADER, J.J., HOFSTADLER, S.A., and CROOKE, S.T. (2003). Human RNase H1 activity is regulated by a unique redox switch formed between adjacent cysteins. J. Biol. Chem. 278, 14906-14912.
18. MARTÍNEZ, V., WANG, L., and TACHÉ, Y. (2001). Central TRH receptor 1 antisense blocks cold-induced gastric emptying but not brain c-fos induction. Peptides 22, 81-90.
19. MATTEUCCI, M.D., and WAGNER, R.W. (1996). In pursuit of antisense. Nature 384, 20-23.
20. MIRAGLIA, L., WATT, A.T., GRAHAM, M.J., and CROOKE, S.T. (2000). Variations in mRNA content have no effect on the potency of antisense oligonucleotides. Antisense Nucleic Acid Drug Dev. 10, 453-461.
21. MISHRA, M., PORTER-KELLEY, J.M., SINGH, P.K., BENNETT, J.R., and CHAUDHURI, G. (2001). Enhanced activity of antisense phosphorothioate oligos against Leishmania amastigotes: Augmented uptake of oligo, ribonuclease H activation, and efficient target intervention under altered growth conditions. Biochem. Pharmacol. 62, 569-580.
22. MYERS, L.P., KRIEG, A.M., and PRUETT, S.B. (2001). Bacterial DNA does not increase serum corticosterone concentration or prevent increases induced by other stimuli. Int. Immunopharmacol. 1, 1605-1614.
23. O'LEARY, R., and O'CONNOR, B. (1995). Thyrotropin-releasing hormone. J. Neurochem. 65, 953-963.
24. PATZEL, V., STEIDL, U., KRONENWETT, R., HAAS, R., and SCZAKIEL, G. (1999). A theoretical approach to select effective antisense oligodeoxiribonucleotides at high statistical probability. Nucleic Acids Res. 27, 4328-4344.
25. PONCE, G., CHARLI, J.L., PASTEN, J.A., ACEVES, C., and JOSEPH-BRAVO, P. (1988). Tissue-specific regulation of pyroglutamate aminopeptidase II activity by thyroid hormones. Neuroendocrinology 48, 211-213.
26. PRATER, C.E., and MILLER, P.S. (2004). 3′-Methylphosphonate- modified oligo-2′-O-methylribonucleotides and their tat peptide conjugates: Uptake and stability in mouse fibroblasts in culture. Bioconjugate Chem. 15, 498-507.
27. SCHAUDER, B., SCHOMBURG, L., KOHRLE, J., and BAUER, K. (1994). Cloning of a cDNA encoding an ectoenzyme that degrades thyrotropin-releasing hormone. Proc. Natl. Acad. Sci. USA 91, 9534-9538.
28. SCHOMBURG, L., and BAUER, K. (1995). Thyroid hormones rapidly and stringently regulate the messenger RNA levels of the thyrotropin-releasing hormone (TRH) receptor and the TRH-degrading ectoenzyme. Endocrinology 136, 3480-3485.
29. SMITH, J., LADI, E., MAYER-PRÖSCHEL, M., and NOBLE, M. (2000). Redox state is a central modulator of the balance between self-renewal and differentiation in a dividing glial precursor cell. Proc. Natl. Acad. Sci. USA 97, 10032-10037.
30. STADTMAN, E.R. (1990). Metal ion-catalyzed oxidation of proteins: Biochemical mechanism and biological consequences. Free Rad. Biol. Med. 9, 315-325.
31. STAHL, J.H., KENDALL, S.K., BRINKMEIER, M.L., GRECO, T.L., WATKINS-CHOW, D.E., CAMPOS-BARROS, A., LLOYD, R.V., and CAMPER, S.A. (1999). Thyroid hormone is essential for pituitary somatotropes and lactotropes. Endocrinology 140, 1884-1892.
32. TAYLOR, A.H., PRINGLE, J.H., BELL, S.C., and AL-AZZAWI, F. (2001). Specific inhibition of estrogen receptor alpha function by antisense oligonucleotides. Antisense Nucleic Acid Drug Dev. 11, 219-231.
33. TEN ASBROEK, A.L.M.A., VAN GROENIGEN, M., NOOIJ, M., and BAAS, F. (2002). The involvement of human ribonucleases H1 and H2 in the variation of response of the cells to antisense phosphorothioate oligonucleotides. Eur. J. Biochem. 269, 583-592.
34. TRENTIN, A.G., ALVAREZ-SILVA, M., and MOURA NETO, V. (2001). Thyroid hormones induces cerebellar astrocytes and C6 glioma cells to secrete mitogenic growth factors. Am. J. Physiol. Endocrinol. Metab. 281, E1088-E1094.
35. TROYANOVSKAYA, M., JAYARAMAN, G., SONG, L., and HEALY, D.P. (2000). Aminopeptidase-A. I. CDNA cloning and expression and localization in rat tissues. Am. J. Physiol. 278, R413-R424.
36. TSO, J.H., SUN, X.H., KAO, T.H., REECE, K.S., and WU, R. (1985). Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNAs: Genomic complexity and molecular evolution of the gene. Nucleic Acids Res. 13, 2485-2502.
37. VARGAS, M.A., BOURDAIS, J., SANCHEZ, S., URIOSTEGUI, B., MORENO, E., JOSEPH-BRAVO, P., and CHARLI, J.L. (1998). Multiple hypothalamic factors regulate pyroglutamyl peptidase II in cultures of adenohypophyseal cells: Role of the cAMP pathway. Neuroendocrinology 10, 199-206.
38. VARGAS, M.A., CISNEROS, M., JOSEPH-BRAVO, P., and CHARLI, J.L. (2000). Regulation of adenohypophyseal pyroglutamyl peptidase II activity by TRH and phorbol esters. Dependence on 3,3′,5′-triiodothyronine and gender. Endocrine 13, 267-272.
39. WAGNER, R.W. (1994). Gene inhibition using antisense oligodeoxynucleotides. Nature 372, 333-335.
40. WEISS, B., DAVIDKOVA, G., and ZHANG, S.-P. (1997). Antisense strategies in neurobiology. Neurochem. Int. 31, 321-348.
41. WIESENHOFER, B., WEIS, C., and HUMPEL, C. (2000). Glial cell-derived neurotrophic factor (GDNF) is a proliferation factor for rat C6 glioma cells: Evidence from antisense experiments. Antisense Nucleic Acid Drug Dev. 10, 311-321.
42. WILK, S., SUEN, C.-H., and WILK, E.K. (1989). Occurrence of pyroglutamyl peptidase II, a specific TRH degrading enzyme in rabbit retinal membranes and in human retinoblastoma cells. Neuropeptides 12, 43-47.
43. WU, C.C.N., LEE, J., RAZ, E., CORR, M., and CARSON, D.A. (2004). Necessity of oligonucleotide aggregation for toll-like receptor 9 activation. J. Biol. Chem. 279(32), 33071-33078.
44. WU, H., LIMA, W.F., and CROOKE, S.T. (1998). Molecular cloning and expression of cDNA for human RNAse H. Antisense Nucleic Acid Drug Dev. 8, 53-61.
45. YEN, P.M. (2001). Physiological and molecular basis of thyroid hormone action. Physiol. Rev. 81, 1097-1142.
46. ZELPHATI, O., UYECHI, L.S., BARRON, L.G., and SZOKA, F.C., Jr. (1998). Effect of serum components on the physicochemical properties of cationic lipid/oligonucleotide complexes and on their interactions with cells. Biochim. Biophys. Acta 1390, 119-133.
47. ZHAO, D., YANG, J., JONES, K.E., GERALD, C., SUZUKI, Y., HOGAN, P.G., CHIN, W.W., and TASHJIAN, A.H., Jr. (1992). Molecular cloning of a complementary deoxyribonucleic acid encoding the thyrotropin-releasing hormone receptor and regulation of its messenger ribonucleic acid in rat GH cells. Endocrinology 130, 3529-3536.